Transderm Scop® (scopolamine) – First-time Generic
July 31, 2017 – Perrigo announced the launch of its AB-rated generic equivalent to GlaxoSmithKline’s Transderm Scop® (scopolamine) transdermal patch, indicated in adults for the prevention of nausea and vomiting associated with motion sickness, and the prevention of nausea and vomiting associated with recovery from anesthesia and/or opiate analgesia and surgery.
Top